NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/28/2026
Back to search
Official data from USPTO
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
ST13
US500000074513062Class
16, 42
Filing
74513062
Registration
1898354
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
03/24/2026
Trademark type
Word
Nice classes
16, 42
Filing date
04/15/1994
Registration date
06/06/1995
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/28/2026
Last transaction
03/24/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
1994-05-00
First use in commerce
1994-05-00
Drawing code
1
Owner type
03
Owner location
Washington, DC, US
Examiner
ZAK, HENRY
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
P. A. (pessoa física)
Pharmaceutical Manufacturers Association
Representatives
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Technical classification
Nice Classes
Class 16Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
pamphlets and booklets regarding pharmaceuticals and the dpharmaceutical PHARMACEUTICAL * pharmaceutical * industry
Class 42
association services promoting the interests of research-based prescription drug manufacturers
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
02/28/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/28/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/28/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
12/04/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/07/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/07/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/07/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/07/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/07/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/28/2014
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
06/28/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/28/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/27/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
06/13/2014
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/14/2006
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/14/2006
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/24/2005
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/24/2005
PLGL
ASSIGNED TO PARALEGAL
06/23/2005
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
05/12/2005
PAPER RECEIVED
05/12/2005
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/05/2001
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
05/02/2001
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
02/01/1996
AMD7
SEC 7 REQUEST FILED
07/20/1995
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/06/1995
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
02/10/1995
CNEA
EXAMINER'S AMENDMENT MAILED
01/30/1995
IUAA
USE AMENDMENT ACCEPTED
01/26/1995
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
10/05/1994
CNRT
NON-FINAL ACTION MAILED
09/08/1994
DOCK
ASSIGNED TO EXAMINER
08/30/1994
IUAF
USE AMENDMENT FILED
08/15/1994
Continuous trademark protection
Get notified about every new filing that threatens PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.